Proliferative and cytolytic potentials of purified human tumor-infiltrating t lymphocytes. Impaired response to mitogen-driven stimulation despite T-cell receptor expression
- 15 November 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 42 (5) , 659-666
- https://doi.org/10.1002/ijc.2910420504
Abstract
Using limiting dilution analysis (LDA) we have previously shown that in most instances, the frequency (F) of proliferative T lymphocyte precursors (PTL-P) was strikingly reduced in tumor-infiltrating lymphocytes (TIL). In this study involving 19 cases, we show that the impaired clonogenic potential of CD2+ TILs is primarily caused by an intrinsic defect rather than to suppressor T cells or to a direct effect of the tumor cells usually present in the culture system. This was demonstrated by experiments in which the F of PTL-Ps was quantitated both in highly purified CD2+ TILs (using a cell-sorter) and in non-purified TIL suspensions (still containing tumor cells), which originated from the same biopsy specimen. The F of PTL-Ps was virtually identical in either sorted or non-sorted suspensions and the data from LDA were always consistent with the single-hit Poisson model, indicating that no suppressor cells interfered with growth of CD2+ TIL. Stimulation of sorted CD2+ TIL in low-density cultures by either phytohemagglutinin or anti-CD3-monoclonal antibody (MAb) indicated that the antigen-dependent activation pathway was impaired, although structurally intact T-cell receptor (TCR) complexes were apparently expressed, as assessed by immunofluorescence. The depressed proliferative response of CD2+ TIL could not be reversed in vitro when phorbol-esters were used in combination with ionomycin, which bypass the TCR. Nevertheless, 180 clones obtained from 8 cases were analyzed for their cytolytic activity. The majority mediated specific lytic activity (against unknown antigens), as assessed by lectindependent cell cytotoxicity, whereas only 6% of them manifested lymphokine-activated killing on appropriate targets.This publication has 15 references indexed in Scilit:
- Clonal analysis of the cytolytic T-cell response to human tumorsImmunology Today, 1987
- Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.The Journal of Experimental Medicine, 1987
- Surface markers of human lymphokine-activated killer cells and their precursors. Analysis at the population and clonal levelInternational Journal of Cancer, 1987
- Presence of Ti (WT31) negative T lymphocytes in normal blood and thymusNature, 1986
- Identification of a putative second T-cell receptorNature, 1986
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The transforming growth factorsTrends in Biochemical Sciences, 1985
- Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.The Journal of Experimental Medicine, 1983
- Glycosphingolipids in Cellular Interaction, Differentiation, and OncogenesisAnnual Review of Biochemistry, 1981